U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

2021
460
Name Type Language
MEDI-19929
Preferred Name English
TEZEPELUMAB
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
TEZEPELUMAB [JAN]
Common Name English
TEZEPELUMAB [USAN]
Common Name English
MEDI-9929
Code English
AMG-157
Code English
MEDI19929
Code English
tezepelumab [INN]
Common Name English
Tezepelumab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G2, ANTI-(HUMAN THYMIC STROMAL LYMPHOPOIETIN) (HUMAN MONOCLONAL MEDI9929 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MEDI9929 .LAMBDA.-CHAIN, DIMER
Systematic Name English
MEDI9929
Code English
Classification Tree Code System Code
NCI_THESAURUS C29712
Created by admin on Mon Mar 31 21:26:36 GMT 2025 , Edited by admin on Mon Mar 31 21:26:36 GMT 2025
FDA ORPHAN DRUG 839721
Created by admin on Mon Mar 31 21:26:36 GMT 2025 , Edited by admin on Mon Mar 31 21:26:36 GMT 2025
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 21:26:36 GMT 2025 , Edited by admin on Mon Mar 31 21:26:36 GMT 2025
Code System Code Type Description
EVMPD
SUB179650
Created by admin on Mon Mar 31 21:26:36 GMT 2025 , Edited by admin on Mon Mar 31 21:26:36 GMT 2025
PRIMARY
WIKIPEDIA
Tezepelumab
Created by admin on Mon Mar 31 21:26:36 GMT 2025 , Edited by admin on Mon Mar 31 21:26:36 GMT 2025
PRIMARY
SMS_ID
100000165774
Created by admin on Mon Mar 31 21:26:36 GMT 2025 , Edited by admin on Mon Mar 31 21:26:36 GMT 2025
PRIMARY
ChEMBL
CHEMBL3707229
Created by admin on Mon Mar 31 21:26:36 GMT 2025 , Edited by admin on Mon Mar 31 21:26:36 GMT 2025
PRIMARY
RXCUI
2587789
Created by admin on Mon Mar 31 21:26:36 GMT 2025 , Edited by admin on Mon Mar 31 21:26:36 GMT 2025
PRIMARY
USAN
BC-128
Created by admin on Mon Mar 31 21:26:36 GMT 2025 , Edited by admin on Mon Mar 31 21:26:36 GMT 2025
PRIMARY
FDA UNII
RJ1IW3B4QX
Created by admin on Mon Mar 31 21:26:36 GMT 2025 , Edited by admin on Mon Mar 31 21:26:36 GMT 2025
PRIMARY
ChEMBL
CHEMBL2109594
Created by admin on Mon Mar 31 21:26:36 GMT 2025 , Edited by admin on Mon Mar 31 21:26:36 GMT 2025
PRIMARY
INN
10172
Created by admin on Mon Mar 31 21:26:36 GMT 2025 , Edited by admin on Mon Mar 31 21:26:36 GMT 2025
PRIMARY
DRUG BANK
DB15090
Created by admin on Mon Mar 31 21:26:36 GMT 2025 , Edited by admin on Mon Mar 31 21:26:36 GMT 2025
PRIMARY
DAILYMED
RJ1IW3B4QX
Created by admin on Mon Mar 31 21:26:36 GMT 2025 , Edited by admin on Mon Mar 31 21:26:36 GMT 2025
PRIMARY
ChEMBL
CHEMBL2109595
Created by admin on Mon Mar 31 21:26:36 GMT 2025 , Edited by admin on Mon Mar 31 21:26:36 GMT 2025
PRIMARY
CAS
1572943-04-4
Created by admin on Mon Mar 31 21:26:36 GMT 2025 , Edited by admin on Mon Mar 31 21:26:36 GMT 2025
PRIMARY
NCI_THESAURUS
C152582
Created by admin on Mon Mar 31 21:26:36 GMT 2025 , Edited by admin on Mon Mar 31 21:26:36 GMT 2025
PRIMARY
ACTIVE MOIETY
TEZEPELUMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966